NCT01711697 An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase PHASE1
NCT01711541 Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01706939 The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01706120 Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab Status UNKNOWN Phase PHASE4
NCT01704287 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002) Status COMPLETED Phase PHASE2
NCT01702714 A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease Status WITHDRAWN Phase PHASE1
NCT01700400 Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer Status COMPLETED Phase PHASE1
NCT01688791 A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) Status TERMINATED Phase PHASE1
NCT01683682 An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2) Status COMPLETED Phase PHASE1
NCT01676649 Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01666977 Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01664754 Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01653470 Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01652794 Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer Status COMPLETED Phase PHASE1
NCT01650376 Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Status UNKNOWN Phase PHASE1/PHASE2